|
|
|
|
LEADER |
03589nmm a2200301 u 4500 |
001 |
EB000627664 |
003 |
EBX01000000000000000480746 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
140122 ||| eng |
020 |
|
|
|a 9781468403534
|
100 |
1 |
|
|a Moore, Joanne I.
|e [editor]
|
245 |
0 |
0 |
|a Pharmacology
|h Elektronische Ressource
|c edited by Joanne I. Moore
|
250 |
|
|
|a 2nd ed. 1990
|
260 |
|
|
|a New York, NY
|b Springer New York
|c 1990, 1990
|
300 |
|
|
|a XI, 251 p
|b online resource
|
505 |
0 |
|
|a Section I: General Principles -- Mechanisms of Drug Action -- Absorption of Drugs -- Distribution of Drugs -- Excretion of Drugs -- Determinants of Plasma Concentrations and Dosing Schedules -- Metabolism of Drugs -- Pharmacogenetics -- Review Questions -- Answers -- Section II: Autonomic Drugs -- Sympathetic Division (Adrenergic) -- Parasympathetic Division (Cholinergic) -- Autonomic Ganglia -- Neuromuscular Blocking Drugs -- Review Questions -- Answers -- Section III: Central Nervous System Drugs -- Anesthetic Agents -- Sedative-Hypnotics -- Alcohols -- Antiepileptic Drugs -- Antiparkinsonism Drugs -- CNS Muscle Relaxants -- CNS Stimulants -- Antidepressants and Lithium -- Antipsychotics -- Opioids -- Drugs of Abuse -- Review Questions -- Answers -- Section IV: Autacoids, Non-Narcotic Analgesics and Agents used in Gout -- Autacoids -- Non-Steroidal Analgesic and Anti-Inflammatory Drugs (NSAIDs) -- Other Anti-Inflammatory Agents used in Rheumatoid Arthritis --
|
505 |
0 |
|
|a Agents used in Gout -- Review Questions -- Answers -- Section V: Renal, Cardiovascular and Hematopoietic Drugs -- Diuretic Agents -- Antidiuretic Drugs -- Cardiovascular Drugs -- Anticoagulants -- Anti-Anemic Drugs -- Review Questions -- Answers -- Section VI: Endocrines -- Thyroid-Antithyroid -- Adrenocortical Steroids -- Parathyroid Hormone and other Factors Affecting Bone Metabolism -- Insulin -- Ovarian Hormones and Ovulatory Agents -- Androgens and Anabolic Steroids -- Anterior Pituitary and Hypothalamus -- Posterior Pituitary Hormones -- Review Questions -- Answers -- Section VII: Chemotherapy -- Chemotherapy -- Chemotherapy of Microbial Diseases -- Antifungal Agents -- Antiviral Drugs -- Antiseptics and Germicides -- Chemotherapy of Neoplastic Diseases (Cancer Chemotherapy) -- Chemotherapy of Parasitic Diseases -- Review Questions -- Answers -- Section VIII: MiscellaneousDrugs -- Gastrointestinal Drugs -- Respiratory Drugs -- Oxytocic Drugs and Uterine Relaxants --
|
505 |
0 |
|
|a Toxicology -- Anti-Migraine Drugs -- Vitamins -- Review Questions -- Answers
|
653 |
|
|
|a Pharmacy
|
653 |
|
|
|a Pharmacology
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
490 |
0 |
|
|a Oklahoma Notes
|
028 |
5 |
0 |
|a 10.1007/978-1-4684-0353-4
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4684-0353-4?nosfx=y
|x Verlag
|3 Volltext
|
082 |
0 |
|
|a 615
|
520 |
|
|
|a Oklahoma Notes/Pharmacology, Second Edition, a major revision and expanded update of the first edition, is designed to serve as a study guide for a review of pharmacology preparatory to Part I of the National Board of Medical Examiners (NBME) examination. All sections have undergone significant revision. The three sections comprising the largest components of the volume - on central nervous system drugs, renal/cardiovascular/hematopoietic drugs, and chemotherapy - have been completely reorganized and rewritten. Examination questions in several instances have been updated; new questions have been added and older questions that no longer appear relevant have been removed
|